Clin Mol Hepatol.
2025 Jan;31(1):323-326. 10.3350/cmh.2024.0932.
Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Affiliations
-
- 1University of Glasgow – Wolfson Wohl Cancer Research Centre, Scotland, UK
- KMID: 2563441
- DOI: http://doi.org/10.3350/cmh.2024.0932
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma
- A Case of Intrahepatic Cholangiocarcinoma in Polycystic Liver Disease
- Image Findings of Sarcomatous Intrahepatic Cholangiocarcinoma Focused on Gd-EOB-DTPA Enhanced MRI: A Case Report
- Review: Analysis of Survival Rate and Prognostic Factors of Intrahepatic Cholangiocarcinoma: 318 Cases in Single Institute
